Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/1996
04/24/1996CN1031641C Process for preparing 8-substituted xanthine
04/24/1996CN1031619C Oxazolidone derivative
04/24/1996CN1031618C Process for preparing mixture with N-aminoalkyl-aza-spiro alkane derivatives as its active composition
04/23/1996USRE35218 For gastrointestinal disorders
04/23/1996US5510480 Certain azacycloalkyl imidazopyrimidines: a new class of GABA brain receptor ligands
04/23/1996US5510385 Analgesics, antiinflammatory agents
04/23/1996US5510381 Therapeutic use of gabapentin, its derivatives
04/23/1996US5510367 Indole derivatives
04/23/1996US5510362 Imidazole, triazole and tetrazole derivatives
04/23/1996US5510361 Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents
04/23/1996US5510350 Useful in treatment or prophylaxis of depression and other central nervous system disorders
04/23/1996US5510345 Biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same
04/23/1996US5510339 Method for the treatment of bronchial asthma by administration of topical anesthetics
04/18/1996WO1996011278A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof
04/18/1996WO1996011270A1 Cloning and characterizing of genes associated with long-term memory
04/18/1996WO1996011209A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
04/18/1996WO1996011195A1 Indole derivatives as 5ht1-like agonists
04/18/1996WO1996011184A1 Colchicine derivatives and the therapeutical use thereof
04/18/1996WO1996011009A1 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound
04/18/1996WO1996011006A1 5-ht1f mediated inhibition of neurogenic meningeal extravasation
04/18/1996WO1996011001A1 Modafinil having defined particle size
04/18/1996WO1996007739A3 Interleukin-1 type 3 receptors
04/18/1996DE4436852A1 Pyrrolyl-tetrahydrobenzochinoxalindione, ihre Herstellung und Verwendung Pyrrolyl tetrahydrobenzochinoxalindione, their preparation and use
04/18/1996DE19533023A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use
04/18/1996CA2202066A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof
04/18/1996CA2201639A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases
04/17/1996EP0707007A1 Amino(thio)ether derivatives as CNS active agents
04/17/1996EP0707006A1 Aroyl-piperidine derivatives
04/17/1996EP0707004A1 1-Arylalcenyl 4-arylmethylpiperazinderivatives, process for their preparation and pharmaceutical composition containing them
04/17/1996EP0706994A1 Melatonergic agents
04/17/1996EP0706797A2 Compositions containing carbohydrates obtained from plants of the family cactacea
04/17/1996EP0706795A2 Catechol diether compounds as inhibitors of TNF release
04/17/1996EP0706525A1 Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace
04/17/1996EP0706524A1 Processes and intermediates for the preparation of 5- 2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one
04/17/1996EP0706523A1 Substituted arylthioalkylthiopyridines
04/17/1996EP0706512A1 Acetamide derivatives and their use for modifying feeding behaviour modifiers
04/17/1996EP0706396A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use
04/17/1996EP0706395A1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
04/17/1996EP0706385A1 Use of isovaleramide as a mild anxiolytic and mild sedative agent
04/17/1996EP0600952B1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
04/17/1996EP0536329B1 R(+)-terazosin
04/17/1996CN1120845A 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
04/17/1996CN1120844A Phosphonomethyldipeptides
04/17/1996CN1120838A Heterocyclic derivatives in the treatment of ischaemia and related diseases
04/17/1996CN1120548A New pseudopeptide compounds of neurokinins, process for preparing them and pharmaceutical compositions containing them
04/17/1996CN1120547A Method for prepn. of NTPS
04/17/1996CN1120541A New tetracyclic piperidine and 1,4-oxazine compounds, a process for their preparation and pharmaceutical compositions containing them
04/17/1996CN1120538A 3-heteroaliphatyl- and 3-hetero (aryl) aliphatyl-2(1H)-quinolone dericatives
04/17/1996CN1031570C Process for preparation of pyrazolopyridine compound
04/17/1996CN1031564C Process for preparation of 4-|-(2-hydroxy-2-phenylethylamino)ethoxy¨ phenyl acet acid and its derivatives
04/16/1996US5508424 Reduced side effects
04/16/1996US5508405 Quinuclidines, their use as medicaments and processes for their preparation
04/16/1996US5508401 N-methyl-d-aspartate antagonists
04/16/1996US5508311 Aliphatic propargylamines as selective MAO-B inhibitors and as neuroprotective agents
04/16/1996US5508305 2, 4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals
04/16/1996US5508301 Ketorolac derivatives with considerably reduced gastro-intestinal irritation and ulceration
04/16/1996US5508288 Indole derivatives as 5HT1C antagonists
04/16/1996US5508284 Treating 5-hydroxytryptamine modulation
04/16/1996US5508276 Having duloxetine core, hydroxypropyl methyl cellulose acetate succinate enteric layer
04/16/1996US5508042 Administering an oral dosage every 12 hours
04/11/1996WO1996010575A1 Biologically active silicon compounds and their therapeutic and cosmetic applications
04/11/1996WO1996010574A1 Method for preparing concentrated biologically active silicon compounds
04/11/1996WO1996010572A1 New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
04/11/1996WO1996010571A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES
04/11/1996WO1996010568A1 Substituted aryl piperazines as neurokinin antagonists
04/11/1996WO1996010415A1 Preparation of mhc-peptide complexes
04/11/1996CA2201519A1 Preparation of mhc-peptide complexes
04/11/1996CA2200358A1 New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
04/11/1996CA2199621A1 Substituted aryl piperazines as neurokinin antagonists
04/11/1996CA2160214A1 1-arylalkenyl 4-arylmethyl piperazine structure-like derivatives; process for preparing them and pharmaceutical compositions containing them
04/10/1996EP0705844A1 Gene encoding cationic amino acid transporter protein
04/10/1996EP0705835A1 Quinoxalic-2,3-diones with an oxa or thiaheterocyclic fused ring
04/10/1996EP0705834A1 Quinoxaline-2,3-diones with an azaheterocyclic fused ring
04/10/1996EP0705832A1 Serotonergic modulators
04/10/1996EP0705830A1 2,3-Cyclic condensed 1,4-dihydropyridines, process for their preparation and their use as K-channel modulators
04/10/1996EP0705820A1 6-Amino-nicotinic acid derivatives and their use as selective K-channel modulators
04/10/1996EP0705819A1 1,4-Dihydropyridin-3,5-dicarboxylates and their use as selective K-channel modulators
04/10/1996EP0705600A1 Use of 5-HT1F-receptor agonists for the treatment of migraine
04/10/1996EP0705433A1 Compositions and methods for anti-addictive narcotic analgesis acivity screening and treatments
04/10/1996EP0705265A1 Novel chemical compounds having pde-iv inhibition activity
04/10/1996EP0705248A1 N-substituted azaheterocyclic carboxylic acids and esters thereof
04/10/1996EP0705247A1 N-substituted azaheterocyclic carboxylic acids and esters thereof
04/10/1996EP0705246A1 N-substituted azaheterocyclic carboxylic acids and esters thereof
04/10/1996EP0705244A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
04/10/1996EP0705100A1 Therapeutic substituted guanidines
04/10/1996EP0705099A1 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
04/10/1996EP0543919B1 Use of heterocyclic amino-alcohol compounds in the manufacture of a medicament for treatment of cns diseases
04/10/1996EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same
04/10/1996CN1120336A Imidazoloquinoxalinone derivatives as eaa antagonists
04/10/1996CN1120042A Substituted 1-(7-chloroquinolin-4-yl)pyrazole-3-carboxamide N-oxide derivatives, method of preparing them and the pharmaceutical compositions in which they are present
04/10/1996CN1120041A Novel benzobiulkyl, preparation of same and parmaceutical composition of same
04/10/1996CN1120038A Substituted ester of piperidine-1-alcohol, preparation and pharmaceutical use of same
04/09/1996US5506347 Lyxofuranosyl analogues of adenosine
04/09/1996US5506268 Use of isovaleramide as a mild anxiolytic and sedative agent
04/09/1996US5506258 Exhibit affinity for the biological receptors of neuropeptides y, which are present in the central and peripheral nervous systems
04/09/1996US5506243 Sulfonamide derivatives
04/09/1996US5506237 Bicyclic nitrogen compounds
04/09/1996US5506234 Psychopharmaceutical agents which bind to benzodiazepine receptors; anxiolytic agents; minimal side effects
04/09/1996US5506230 Oil in water emulsion consists of 2,3-dihydro-1h indene cmpound, an oil, phospholipid as an emulsifier, glycerol as an isotonic agent and water; useful for improving anoxemic and hypoxic syndromes, prevents arrythemia and heart failure
04/09/1996US5506229 Skeletal and muscle disorders
1 ... 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 ... 1833